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The late Frits Sobels developed a parallelogram model to estimate genetic risk to humans based
on experimental data in somatic cells (peripheral blood) of exposed animals and humans and on
data from progeny studies of exposed animals (mice). Recently, an extension to the original paral-
lelogram model was proposed to bridge the gap of extrapolation between rodent and human
germ cells by studying sperm samples. The comparison in the parallelogram of rodent/human
sperm data with data from rodent progeny tests to derive at an estimate of human progeny at
risk is more promising. Therefore, data on all possible end points, DNA adducts, mutations, chro-
mosomal aberrations, and aneuploidy, should be obtained in sperm of exposed rodents and
humans. The technology from somatic cell studies is available or adaptable to sperm studies.
Sperm samples lend themselves to automated analyses because they are a homogeneous cell
population. By flow cytometry or image analysis, large cell samples can be studied per individual.
Animal experiments could be conducted in the actual range of chronic human exposure to low
doses. The acceptability of extrapolation from the high acute doses so far used in animal experi-
ments to low chronic doses of human exposure could be assessed. Proof could be obtained in
human germ cells for the assumption that data from animal experiments can be extrapolated to
humans. Data from transgenic rodent systems may play an important role in the extension of the
parallelogram approach to genetic risk estimation by providing a link between cancer and genetic
risk estimates. Environ Health Perspect 104(Suppl 3):619-624 (1996)




During a recent IPCS (International
Program on Chemical Safety) Workshop
on the Harmonization ofRisk Assessment
for Carcinogenicity and Mutagenicity, the
subgroup dealing with germ cell mutagenic
risk assessment developed a scheme for the
identification ofgerm cell mutagens (1). In
this scheme, the male rodent dominant
lethal test was identified as the method of
choice to recognize germ cell mutagens.
Based on information from the male
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rodent dominant lethal test, preventive
measures against exposure to mutagens are
possible by classifying the chemical as a
germ cell mutagen. Many chemicals have
been or are being used unavoidably such as
ionizing radiation and cancer therapeutic
agents, to name the most obvious; for these
agents, germ cell mutagenicity in rodents is
well established by demonstrating induced
transmissible mutations. It is an often-cited
fact that the induction ofgenetic disease in
humans has not been proven by epidemio-
logical studies (2); there is a gap between
demonstrating induced mutational events
(3) and assessing an increased incidence
of genetic disease in progeny ofexposed
humans, which we are currently not able to
bridge (4). It will require a huge effort to
improve genetic epidemiology in ord& to
provide reliable information on environ-
mentally induced genetic disease. Major
improvements are needed in estimating
spontaneous mutation frequencies underly-
ing the prevalence ofgenetic disease and in
designing sensitive parameters to determine
increases in genetic disease such as sentinel
phenotypes (5). Although available epi-
demiological studies ofradiation-exposed
populations or cancer patients do not
demonstrate induced genetic disease, we
should not dismiss the serious danger that
environmental exposure to mutagens
increases the genetic burden ofhumans.
In the absence of direct proof of a
human genetic risk and its magnitude, the
extrapolation from animal models to
humans is the only method of choice.
Several studies have shown that radiation
or chemicals can increase chromosomal
aberrations in human germ cells (6-10).
These studies provide proofthat the human
germ cell genome is mutated similar to the
rodent germ cell genome; however, the
methodologies (human testicular biopsies
orhuman sperm/hamster egg in vitrofertil-
ization) are too impractical to be employed
routinely. Modern molecular techniques
provide tools to detect genetic alterations
including DNA damage, mutations, and
aneuploidy in rodents and humans. The
sperm studies have the advantage that they
cover the extrapolation gaps between
rodents and humans, but they have the
disadvantage ofassessing the genetic alter-
ations in germ cells as opposed to geneti-
cally affected progeny. Incorporating the
sperm studies into the parallelogram
approach of genetic risk assessment (11)
will be an important step to improve the
validity ofquantifying human genetic risk
based on animal experiments.
Present Methods
of Germ Cell Studies
The dominant lethal test (12) has been
mentioned above as the tool to detect germ
cell mutagenicity. It is commonly per-
formed with acutely treated male animals
that are mated at different intervals after
treatment to cover the entire period of
male germ cell development (13). This
protocol provides valuable information on
sensitive stages, which can be different
from chemical to chemical even ifthey are
structurally related (14). Because the dom-
inant lethal assay determines the frequency
ofgenetic alterations (unstable chromoso-
mal aberrations) that lead to embryonic
death, it does not lend itselfto genetic risk
quantification. Quantification ofgerm cell
mutagenicity is performed by testing prog-
eny for various marker genes, whereby the
information from the dominant lethal
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Mutations to altered protein charge
Specific enzyme activity mutations
Mutations at histocompatibility loci
Reciprocal translocations
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assay can serve as a guide in respect to
acute dosing and possible sensitive germ
cell stages.
The present methods of progeny
studies employ almost exclusively the
mouse as the model animal (Table 1). The
classical progeny test is the specific locus
test that employs six or seven recessive
marker genes developed in Oak Ridge and
Harwell and uses mouse tester stocks
which are homozygous for these genes
(16,17). All progeny of crosses between
the tester strain parent (usually the female)
and the wildtype parent (usually the
treated male) will be heterozygous, display-
ing the dominant wild type phenotype.
If a mutation, spontaneous or induced,
leads to a recessive allele at one of the
respective wildtype loci in a paternal germ
cell, the resulting offspring will express the
mutant phenotype. Originally, this test has
been used to determine the mutation fre-
quencies in spermatogonial stem cells by
permanently mating the treated males to
tester-stock females. From the point of
genetic risk assessment, spermatogonial
stem cells are the most important germ
cells because mutations induced in the
stem cells will generate mutated sperm
throughout the reproductive life ofan indi-
vidual (mouse or man); however, only few
chemical mutagens and ionizing radiation
induce mutations in stem cells. Most
chemical mutagens are effective in later
developmental stages such as spermatocytes,
spermatids, or spermatozoa (28). It is com-
paratively difficult to test the differentiated
post-stem cell stages with their limited life
span. Repeated experiments are necessary
to obtain the recommended samp
12,000 to 18,000 progeny (29)
one ofthe characteristics and, at
time, the main disadvantage ofall
tests. Due to the low spontaneot
tion frequency (in the order of I
any of the employed marker gen
numbers ofprogeny have to be c
Clear and easy-to-detect phenot
necessary to screen the required
ofprogeny, and large animal facili
prerequisite. They only exist in
half a dozen laboratories aro
world. It becomes understanda
only a small database exists for th
locus assay even though it has b
for decades.
Another disadvantage of the
locus assay is the fact that only six
loci are being tested. Their mt
varies widely, and the question
raised ofhow representative thesc
for the entire genome. To incr
number oftested loci by a factor c
multiple end point approach was d
by Ehling et al. (30). In this appr
progeny are screened for the 7
recessive loci and for 23 loci co
protein-charge changes (22-24)
for enzyme activity alterations (
about 30 loci coding for dominan
mutations (21). The results with
radiation and two selected chemica
nitrosourea (ENU) and procarbazi
cate that the mutability of the (
marker genes varies by an order o
tude, with the dominant catara
being 10 times less mutable t
morphological specific locus genes.
)le size of Other genetic end points used for
t. This is progeny testing have certain disadvantages
the same because they are extremely laborious. The
progeny test for dominant skeletal abnormalities
us muta- (19,31) has been modified to ease the
1/106) of amount ofanimal breeding, but the modi-
ies, large fied test procedure does not prove the
)bserved. heritability ofthe observed variant pheno-
types are types (20). Histocompatibility loci have
numbers also been used, but the identification of
ities are a variants by skin graft rejection is extremely
less than difficult (26). Dominant visible mutations
und the should be and are assessed along with
ible that other phenotypes; however, they require
.e specific highly experienced observers and are easily
een used overlooked (18).
Transmissible chromosomal damage is
specific tested in the heritable translocation assays.
to seven The most arduous procedure by far is the
atability determination ofthe translocation carriers
is often among the progeny by reduced fertility, fol-
e loci are lowed by cytogenetic confirmation. Because
rease the the spontaneous translocation frequency is
)f 10, the two orders of magnitude higher than for
leveloped the phenotypic markers, it requires fewer
oach, the progeny to be screened (27).
nstrpolcig Present State ofthe Art
, 12 loci of Risk Estimates
25), and Genetic risk estimates can be seen in two
t cataract ways: counseling exposed individuals and
ionizing determining the risk for a certain popula-
als, ethyl- tion. Two major methods of genetic risk
ine, indi- quantification for mutagenic agents can be
different discriminated (32). The indirect method
fmagni- expresses the genetic risk ensuing a certain
Lct genes exposure as a relative increase above the
-han the spontaneous mutation frequency and pre-
dominantly uses data of the specific locus
test or the heritable translocation test. The
louse (Mus doubling dose is determined in animal experiments as the theoretical dose of a
chemical mutagen that induces as many
Dtatioateoub mutational events per generation as occur
spontaneously. The relative genetic risk for
o 0.9 humans is then calculated as the ratio
o 0.2 between the population or individual expo-
0.008 sure dose and the doubling dose derived
27* from animal experiments. The indirect
method is applicable to determinations of
0.07 individual risks, as well as to population
risks. It can only be expected that the indi-
0.07 rect risk estimate states orders of mag-
0 nitude rather than precise values. This
information on increment over sponta-
1.0 neous mutation frequencies has two major
drawbacks. The uncertainties about the
40c spontaneous mutation frequencies leading
to genetic disease in humans have already
per gamete been mentioned. The second problem is
the assessment ofthe population dose.
Generation, methods,
References number of loci screened
(16,17) Fl, externally visible traits,
6 or 7 recessive loci
(18) F1, externallyvisible traits,
-60 loci
(19,20) F1, skeletal defects,
12 indicatoranomalies
(21) F1, lens opacities,
-30 loci
(22-24) F1, variant electrophoretic
patterns of proteins, 20-30 loci
(25) F1, blood enzyme activity
changes, 12 loci
(26) F1, skin graft rejection by 80
days, 30-50 loci
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Table 1. Tests developed for systematic screening of progeny for transmitted mutations in the m
musculus).a
"Data modified from Favor (15). bMutations per locusxgamete (x 10-5). cReciprocal translocations
(Xi0-5). *Variants, heritability not proven.
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The direct method gives the expected
number ofnewly occurring cases ofgenetic
disease in a certain exposed human popula-
tion independent of the spontaneous
mutation frequencies. It is based on data
from the cataract test or other tests employ-
ing dominant marker genes. The mutation
frequency to dominant traits is determined
experimentally for a particular organ sys-
tem and multiplied by a factor for all possi-
ble dominant mutations in humans and
the human exposure dose.
The application of both methods to
calculations ofhuman genetic risks requires
certain assumptions: the various biological
and exposure factors affect the magnitude
of the induced mutation frequency in a
similar way and to a similar extent in mice
and humans, and there is a linear or linear
quadratic dose response.
The main uncertainty lies in the second
assumption. The extrapolation occurs from
high acute exposure to low chronic expo-
sures of the human environmental expo-
sure situation. There are no data with any
of the above assays on low chronic expo-
sure to chemical mutagens. Fractionation
experiments with ENU have shown that
the data gave the best fit to a threshold
model (33). Saturation ofspermatogonial
repair capacities is the most likely reason
for a threshold to occur. At a low chronic
exposure situation, repair capacities might
not be affected and all DNA lesions may
be dealt with appropriately; however,
repair can make mistakes leading to muta-
tions. With chronic exposure, these muta-
tions, albeit rarely induced, can accumulate
in the stem cell population. Therefore, it is
urgent that exposures other than acute high
dose exposures are tested in germ cells.
Mutation data from spermatogonial
stem cell studies for a quantification of
genetic risk are only available for radiation
and a few chemical mutagens such as the
alkylating agents ENU, mitomycin C, pro-
carbazine, and triethylenemelamine. First
attempts have been made to quantify the
genetic risk by calculating the doubling
dose based on heritable translocation
induction for the occupational mutagens
acrylamide and ethylene oxide (34,35).
These scanty data demonstrate the need for
improved methodologies that allow a
quicker gathering ofquantitative germ cell
information andrequire fewer animals.
Future Directions
of Germ Cell Testing
Future work on germ cell mutagenesis will
probably extend in two areas. The relevance
ofthe mouse data will have to be improved
by using genetic markers that are relevant
to human hereditary diseases, and the
development and use ofmouse models for
human genetic diseases and developmental
defects will be a major goal offuture work
with the traditional progeny test. Another
trend for future developments includes
molecular techniques to assess mutational
processes. One promising development is
the introduction of transgenic mice in
mutation research. Another emerging
application of molecular techniques is
directed towards the analysis ofsperm from
experimental rodents and humans for
mutations, DNAdamage, and aneuploidy.
Transgenic Mouse Germ
Cell Studies
With the transgenic mouse systems using
the X shuttle vector lacIq, lacZa (Big Blue
mice), it was shown that mutations
induced by ENU in male germ cells could
be successfully assessed (36). Transversions,
transitions, and deletions ofbase pairs were
identified (37). Interestingly, the sponta-
neous mutation frequencies are an order of
magnitude higher in somatic tissues than
in male germinal tissue (38); however, the
mutation frequencies induced by ENU and
chlorambucil are mostly in the same order
of magnitude in testicular tissue as in
somatic tissues (39). The database contains
only these two model germ cell mutagens
so far (40).
The advantage ofthe transgenic mouse
system is that somatic and germinal cell
samples can be studied within an animal to
quantify and compare the mutational
events that may lead to cancer or genetic
disease. The mutations can be sequenced
and the nature of the mutational process
can thus be determined. A collaborative
study on transgenic germ cell mutation
assays, which has been initiated recently
(41), will generate data for ENU (as the
standard), methyl methanesulfonate, and
isopropyl methanesulfonate. Details ofthe
sampling protocol (site and timing) for
male germ cells and procedures oflambda
packaging of DNA will be tested and
standardized. It remains to be determined
how well the transgenic mouse systems
recognize germ cell mutagens qualitatively,
in regard to germ cell stage sensitivity,
and quantitatively.
Sperm Assays
Molecular techniques can now be applied
to studies ofsperm for all classical muta-
genicity end points, mutation induction,
DNA breakage, and aneuploidy. These
methods for the first time provide tools to
compare germ cell effects ofexternal expo-
sure between rodents and human subjects.
The comparison, on a quantitative basis,
will substantiate or disprove the validity of
the classical extrapolation ofanimal data to
human genetic risk.
A method developed by Parry et al.
(42) can detect base changes in restriction
enzyme recognition sites (RSM). This
method is based upon the detection of
DNA sequences resistant to the cutting
action ofspecific restriction enzymes and
the amplification ofthese resistant sequences
using polymerase chain reaction. The RMS
method can be used to study induced base
changes in any species, tissue, and genes of
known DNA sequence for which unique
DNA primers are available, and which
contain a number of unique restriction
enzyme recognition sites. The RSM method
has been adapted to testicular samples, and
experiments using the technique to com-
pare mutation induction between somatic
and sperm cells and between rodent and
human tissue samples are presently under
way JM Parry, personal communication).
To detect DNA breakage, the single cell
gel electophoresis assay, the comet assay,
has gained worldwide recognition (43,44).
DNA breakage is required for the forma-
tion ofstructural chromosome aberrations
(clastogenicity), and thus the comet assay
can serve as an indicator test to assess the
potential clastogenic effect of a chemical.
The application of the comet assay to
sperm encounters certain technical prob-
lems that are being addressed and that will
be solved soon. It is very likely that this
technique will be much quicker than the
laborious and time-consuming analysis
ofstructural chromosomal damage in first
cleavage divisions of the mouse sperm
genome after in vivo fertilization (45) or
of the human sperm genome after in vitro
fertilization with hamster eggs (7-10).
Researchers hope that the comet assay in
sperm will give a qualitatively similar
answer to cytogenetic sperm assays as it
already does in somatic cells.
Aneuploidy is a major cause ofhuman
genetic disease; however, this mutational
end point has been neglected in genotox-
icity testing guidelines and in genetic
risk assessment exercises because validated
test procedures were not available. In
recent years, molecular cytogenetic tech-
niques have brought a major breakthrough.
Labeled repetitive chromosome-specific
DNA probes were employed to detect the
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absence or additional presence ofindividual
chromosomes in nondividing cells. The
fluoresence in situ hybridization (FISH)
technique using these probes has been suc-
cessfully employed to mouse and human
sperm for the detection of nullisomy or
disomy of individual chromosomes and
diploidy ofthe sperm genome (46-49). At
present, several laboratories in Europe have
started to use the FISH method to analyze
human sperm from individuals after
chemotherapy or unsuccessful self-poison-
ing attempts and to compare the data with
those of rodents (rats and mice), which
were treated according to the human expo-
sure scheme. This technique bears great
potential to finally provide a validated
internationally accepted procedure for ane-
uploidy testing in genotoxicity test guide-
lines and to generate data for the hitherto
missing end point in genetic risk estimates.
The Parallelogram Approach
A parallelogram model to estimate genetic
risk to humans was developed by F.H.
Sobels (11); this model was based on exper-
imental data in somatic cells (peripheral
blood) ofexposed animals and humans and
on data from progeny studies of exposed
animals (mice). In this parallelogram, DNA
adduct measurement is regarded as the
internal dose assessment (50). Recendy, an
extension to the original parallelogram
model was proposed (Figure 1) to bridge
the gap of extrapolation between rodent
and human germ cells by studying sperm
samples (51).
It is very difficult to extrapolate from
mutation rates in somatic cells to rates of
genetically altered progeny. It is more
promising to compare rodent and human
sperm data with data from rodent progeny
tests to derive an estimate ofhuman prog-
eny at risk. Therefore, data on all possible
end points, DNA adducts, mutations,
chromosomal aberrations, and aneuploidy,
should be obtained in sperm ofexposed
rodents and humans. Sperm samples lend
Rodents Humans
Peripheral blood Peripheral blood
Adducts (hemoglobin or DNA) 4 Adducts (hemoglobin or DNA)
Mutations (HPRT) Mutations(HPRT)
CA, MN, SCE CA, MN, SCE
Aneuploidy (FISH) Aneuploidy(FISH)
Sperm nn- Sperm
Adducts (DNA) 4 4 Adducts (DNA)
Mutations (RSM) Mutations (RSM)
DNA breakage (Comet) DNA breakage (Comet)
Aneuploidy (FISH) Aneuploidy(FISH)





Figure 1. Extension of the parallelogram model. Abbreviations: HPRT, hypoxanthine guanine phosphoribosyltrans-
ferase; CA, chromosomal aberrations; MN, micronuclei; SCE sister chromatid exchange; RSM, restriction site
mutations.The parallelogram model for genetic risk estimates of F.H. Sobels (11) is complemented by analyses of
DNA adducts and of all genetic end points in sperm of rodents and humans. The intermediate step of sperm
analysis between tests in peripheral blood and progeny testing will provide a better correlation efficiency in
the parallelogram.
themselves to automated analyses because
they are a homogeneous cell population.
By flow cytometry or image analysis, large
cell samples can be studied per individual.
Animal experiments could be conducted in
the actual range of chronic human expo-
sure to low doses. The acceptability of
extrapolation from the high acute doses so
far used in animal experiments to low
chronic doses ofhuman exposure could be
assessed. Proof that data from animal
experiments can be extrapolated to humans
could be obtained in human germ cells.
Conclusion
The area ofmutation research developed
from radiation genetics, and the concern
was that heritable damage could be induced
not only by ionizing radiation but also
by mutagenic chemicals. Thus, in the
beginning, the genetic burden to future
generations was the driving force for the
development in the research area. With the
recognition ofcorrelations between soma-
tic mutations and cancer development and
with the observation in the mid-1970s that
rodent carcinogens were also bacterial
mutagens, the concern and the efforts were
directed towards carcinogen identification.
Mutation research benefited from this con-
cern by the introduction of international
guidelines for mutagenicity testing; how-
ever, the original concern of chemically
increased genetic ill health in the human
population was only maintained by a few
researchers. Presently, the technologies of
molecular genetics provide tools to open
new horizons to germ cell mutagenicity
testing, and the field ofmutation research
is receiving new impulses for improvement
ofgenetic risk estimation.
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